Bortezomib Completed Phase 3 Trials for Chronic Renal Failure With Uremic Nephropathy Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01208818Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy